ConductScience.org, home

Paper36980665

The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?

Alsalloum A and 2 others. Cancers (Basel), 2023. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy? Papers, record 36980665. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980665

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Melanoma-Associated Antigen Family A (MAGE-A): A Promising Target for Cancer Immunotherapy?
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
4.18
iCite
Revised in PubMed
2023-03-31
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alsalloum AAlaahttps://orcid.org/0000-0002-4395-5822
2Shevchenko JAJulia A
3Sennikov SSergeyhttps://orcid.org/0000-0002-7366-7768

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
21-65-00004Russian Science Foundation (RSF)PubMed

Source PubMed

Download CSV of grants

References68

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119088187Genome-wide analysis of cancer/testis gene expression.Proc Natl Acad Sci U S A2008https://conductscience.org/library/papers/19088187PubMed
216687489Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells.Mol Cancer Res2006https://conductscience.org/library/papers/16687489PubMed
310189127Expression of the MAGE gene family in human hepatocellular carcinoma.Cancer1999https://conductscience.org/library/papers/10189127PubMed
416299236Cancer-testis genes are coordinately expressed and are markers of poor outcome in non-small cell lung cancer.Clin Cancer Res2005https://conductscience.org/library/papers/16299236PubMed
51840703A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.Science1991https://conductscience.org/library/papers/1840703PubMed
629763778MAGE-A antigens as targets for cancer immunotherapy.Cancer Treat Rev2018https://conductscience.org/library/papers/29763778PubMed
725315972High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma.Sci Rep2014https://conductscience.org/library/papers/25315972PubMed
810523621DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-specific genes with a CpG-rich promoter.Mol Cell Biol1999https://conductscience.org/library/papers/10523621PubMed
99679755Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer.Int J Cancer1998https://conductscience.org/library/papers/9679755PubMed
1029908991MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial.Lancet Oncol2018https://conductscience.org/library/papers/29908991PubMed
1130915277Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies.Front Oncol2019https://conductscience.org/library/papers/30915277PubMed
1225363021Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.BMC Cancer2014https://conductscience.org/library/papers/25363021PubMed
1327163739Isolation and Characterization of an HLA-DPB1*04: 01-restricted MAGE-A3 T-Cell Receptor for Cancer Immunotherapy.J Immunother2016https://conductscience.org/library/papers/27163739PubMed
1425755744High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival.Int J Clin Exp Pathol2015https://conductscience.org/library/papers/25755744PubMed
1529177094
Safety and immunogenicity of MAGE-A3 cancer immunotherapeutic with dacarbazine in patients with MAGE-A3-positive metastatic cutaneous melanoma: an open phase I/II study with a first assessment of a predictive gene signature.
ESMO Open2017https://conductscience.org/library/papers/29177094PubMed
167672823Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene.Immunogenetics1995https://conductscience.org/library/papers/7672823PubMed
1723926201Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.Sci Transl Med2013https://conductscience.org/library/papers/23926201PubMed
1812548548Cancer/testis-associated genes: identification, expression profile, and putative function.J Cell Physiol2003https://conductscience.org/library/papers/12548548PubMed
1935372008Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors.Front Oncol2022https://conductscience.org/library/papers/35372008PubMed
2019417017Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.Clin Cancer Res2009https://conductscience.org/library/papers/19417017PubMed

See all 68 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42971725Enhanced melanoma-specific cytotoxic T-cell expansion and the clinical outcomes with simlukafusp alfa and pembrolizumab following checkpoint inhibitor progression.J Immunother Cancer2026https://conductscience.org/library/papers/42971725PubMed
42755095MAGEA Family Gene Expression Influences Survival in Intestinal-Type Gastric Cancer.Cancer Med2026https://conductscience.org/library/papers/42755095PubMed
42753002Cancer-Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives.J Immunol Res2026https://conductscience.org/library/papers/42753002PubMed
42500564The Construction and Preclinical Evaluation of Antitumor Activity of a Novel MIgG-OXA ADC in Lung Adenocarcinoma.Oncol Res2026https://conductscience.org/library/papers/42500564PubMed
42121790A Novel Recombinant MAGE-B10-HSP110 Fusion Protein Enhances Innate and Adaptive Immune Responses in Mice: A Potential Vaccine Candidate for Canine Mammary Tumors.Animals (Basel)2026https://conductscience.org/library/papers/42121790PubMed
42079663Translational strategy to support the first-in-human study of a TCR-like T cell bispecific with an in vitro-based safety approach.Front Immunol2026https://conductscience.org/library/papers/42079663PubMed
42041682A Pan-Cancer Transcriptomic Signature for Conserved Molecular Programs Underlying Premalignant-Malignant Progression Across Common Carcinomas.Dent J (Basel)2026https://conductscience.org/library/papers/42041682PubMed
41426498Solid tumor rejection using personalized incompatible human leukocyte antigen (HLA) and blood group ABH antigens.Explor Med2025https://conductscience.org/library/papers/41426498PubMed
41309872In silico design of a multi-epitope vaccine against the triple negative breast cancer.Sci Rep2025https://conductscience.org/library/papers/41309872PubMed
41209563Advances in Tumor Antigen Vaccines: A New Frontier in Cancer Immunotherapy.Int J Med Sci2025https://conductscience.org/library/papers/41209563PubMed
41173834S100A9 enhances tumor immune suppression and cancer cell survival in small cell lung cancer.Cell Death Dis2025https://conductscience.org/library/papers/41173834PubMed
41012179Messenger RNA and Plasmid DNA Vaccines for the Treatment of Cancer.Vaccines (Basel)2025https://conductscience.org/library/papers/41012179PubMed
40943226Comparison of Current Immunotherapy Approaches and Novel Anti-Cancer Vaccine Modalities for Clinical Application.Int J Mol Sci2025https://conductscience.org/library/papers/40943226PubMed
40721826Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.Acta Neuropathol Commun2025https://conductscience.org/library/papers/40721826PubMed
40655139The multifaceted roles of mucins family in lung cancer: from prognostic biomarkers to promising targets.Front Immunol2025https://conductscience.org/library/papers/40655139PubMed
40631515An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer.Oncoimmunology2025https://conductscience.org/library/papers/40631515PubMed
40625850Lung cancer vaccine strategies: exploring the spectrum from traditional to RNA-based platforms.Front Bioeng Biotechnol2025https://conductscience.org/library/papers/40625850PubMed
40535484Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges.World J Transplant2025https://conductscience.org/library/papers/40535484PubMed
40473741Bioinformatics analysis of innovative multi-epitope vaccine utilizing MAGE-A, MAM-A, and Gal-3 for breast cancer management.Sci Rep2025https://conductscience.org/library/papers/40473741PubMed
40167762A new era of cancer immunotherapy: vaccines and miRNAs.Cancer Immunol Immunother2025https://conductscience.org/library/papers/40167762PubMed

See all 38 cited byDownload CSV of cited by

Genes32

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD40LG959PubTator's text mininghttps://conductscience.org/library/genes/959NCBI Gene
CD70970PubTator's text mininghttps://conductscience.org/library/genes/970NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CTAG1A246100PubTator's text mininghttps://conductscience.org/library/genes/246100NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene
DNMT11786PubTator's text mininghttps://conductscience.org/library/genes/1786NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
HLA-DPB13115PubTator's text mininghttps://conductscience.org/library/genes/3115NCBI Gene
IFN1@3438PubTator's text mininghttps://conductscience.org/library/genes/3438NCBI Gene
IFNG3458PubTator's text mininghttps://conductscience.org/library/genes/3458NCBI Gene
MAGEA14100PubTator's text mininghttps://conductscience.org/library/genes/4100NCBI Gene
MAGEA104109PubTator's text mininghttps://conductscience.org/library/genes/4109NCBI Gene
MAGEA124111PubTator's text mininghttps://conductscience.org/library/genes/4111NCBI Gene
MAGEA24101PubTator's text mininghttps://conductscience.org/library/genes/4101NCBI Gene
MAGEA34102PubTator's text mininghttps://conductscience.org/library/genes/4102NCBI Gene
MAGEA44103PubTator's text mininghttps://conductscience.org/library/genes/4103NCBI Gene
MAGEA64105PubTator's text mininghttps://conductscience.org/library/genes/4105NCBI Gene

See all 32 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980665

GET https://conductscience.org/api/papers/v1/36980665/references?page=2